Michael N. Weedon

74.2k citations

182 papers · 11.4k indexed · 6 hit papers · h-index 56

Impact in

Genetics top 0.1%
- Genetic Associations and Epidemiology
- Diabetes and associated disorders
- Genetic Mapping and Diversity in Plants and Animals
Endocrinology, Diabetes and Metabolism top 0.5%
- Diabetes Management and Research
- Diabetes Treatment and Management

Papers in

Genetics 106
- Genetic Associations and Epidemiology 42
- Diabetes and associated disorders 36
- Genetics and Neurodevelopmental Disorders 13
- Genomics and Rare Diseases 13
Endocrinology, Diabetes and Metabolism 43
- Diabetes Management and Research 19

Co-authors: Timothy M. Frayling Andrew T. Hattersley Andrew R. Wood Mark I. McCarthy Joel N. Hirschhorn Dennis H. Greer Beverley M. Shields Jian Yang
Journals: Diabetes (26 papers)Diabetologia (21 papers)Diabetes Care (9 papers)The American Journal of Human Genetics (8 papers)Human Molecular Genetics (7 papers)
Partner nations: United Kingdom United States Australia

In The Last Decade

Michael N. Weedon

172 papers receiving 11.2k citations

Hit Papers

6 papers align trajectories log scale

Development and Standardization of an Improved Type 1 Diabetes Genetic Risk Score for Use in Newborn Screening and Incident Diagnosis 2019 · 206 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2019 Diabetes Care
2018 Human Molecular Genetics
2018 Scientific Reports
2017 The Lancet Diabetes & Endocrinology
2012 Nature Genetics
2003 Diabetes

Peers

Countries citing papers authored by Michael N. Weedon

Since Specialization

Citations

This map shows the geographic impact of Michael N. Weedon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael N. Weedon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael N. Weedon more than expected).

Fields of papers citing papers by Michael N. Weedon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael N. Weedon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael N. Weedon. The network helps show where Michael N. Weedon may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael N. Weedon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael N. Weedon Line = papers co-authored together Michael N. Weedon links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Population Prevalence, Penetrance, and Mortality for Genetically Confirmed MODY The Journal of Clinical Endocrinology & Metabolism ·Luke N Sharp, Kevin Colclough, James H. Leech, Stuart J Cannon, Thomas W. Laver, Andrew T. Hattersley, Michael N. Weedon, Kashyap Patel	2025	0
2	Clinical utility of self-reported sleep duration and insomnia symptoms in type 2 diabetes prediction Diabetologia ·Alison K. Wright, Tianyi Huang, Matthew Carr, Arjun D Premdayal, Sushant Saluja, Hassan S. Dashti, Simon Anderson, David Ray, Samuel E. Jones, Andrew R. Wood, Timothy M. Frayling, Michael N. Weedon, Jacqueline M. Lane, Richa Saxena, J. Liu, Jack Bowden, Debbie A. Lawlor, Susan Redline, Martin K. Rutter	2025	0
3	Colorectal cancer risk stratification using a polygenic risk score in symptomatic primary care patients—a UK Biobank retrospective cohort study European Journal of Human Genetics ·Bethan Mallabar-Rimmer, Samuel WD Merriel, Amy P. Webster, Leigh Jackson, Andrew R. Wood, Matthew Barclay, Jessica Tyrrell, Katherine S. Ruth, Christina Thirlwell, Richard A. Oram, Michael N. Weedon, Sarah Bailey, Harry Green	2024	1
4	Pharmacogenetics of Toxicities Related to Endocrine Treatment in Breast Cancer: A Systematic Review and Meta-analysis Cancer Genomics & Proteomics ·Kinan Mokbel, Michael N. Weedon, Victoria Moye, Leigh Jackson	2024	3
5	Hyperglycaemia is a causal risk factor for upper limb pathologies International Journal of Epidemiology ·Harry Green, Ella Burden, Ji Chen, Jonathan P Evans, Kashyap Patel, Andrew R. Wood, Robin N. Beaumont, Jessica Tyrrell, Timothy M. Frayling, Andrew T. Hattersley, Richard A. Oram, Jack Bowden, Inês Barroso, Chris Smith, Michael N. Weedon	2024	2
6	The Role of ONECUT1 Variants in Monogenic and Type 2 Diabetes Mellitus Diabetes ·James Russ‐Silsby, Kashyap Patel, Thomas W. Laver, Gareth Hawkes, Matthew B. Johnson, Matthew N. Wakeling, Prashant P. Patil, Andrew T. Hattersley, Sarah E. Flanagan, Michael N. Weedon, Elisa De Franco	2023	8
7	Identifying type 1 and 2 diabetes in research datasets where classification biomarkers are unavailable: assessing the accuracy of published approaches Journal of Clinical Epidemiology ·Nicholas J. Thomas, Andrew McGovern, Katherine Young, Seth A. Sharp, Michael N. Weedon, Andrew T. Hattersley, John Dennis, Angus G. Jones	2022	14
8	Assessing the Causal Role of Sleep Traits on Glycated Hemoglobin: A Mendelian Randomization Study Diabetes Care ·Junxi Liu, Rebecca C. Richmond, Jack Bowden, Ciarrah-Jane Barry, Hassan S. Dashti, Iyas Daghlas, Jacqueline M. Lane, Samuel E. Jones, Andrew R. Wood, Timothy M. Frayling, Alison K. Wright, Matthew Carr, Simon Anderson, Richard Emsley, David Ray, Michael N. Weedon, Richa Saxena, Debbie A. Lawlor, Martin K. Rutter	2022	37
9	The relationship between islet autoantibody status and the genetic risk of type 1 diabetes in adult-onset type 1 diabetes Diabetologia ·Nicholas J. Thomas, Helen C. Walkey, Akaal Kaur, Shivani Misra, Nick Oliver, Kevin Colclough, Michael N. Weedon, Desmond G. Johnston, Andrew T. Hattersley, Kashyap Patel	2022	15
10	A single nucleotide polymorphism genetic risk score to aid diagnosis of coeliac disease: a pilot study in clinical care Alimentary Pharmacology & Therapeutics ·Seth A. Sharp, Samuel E. Jones, Robert Kimmitt, Michael N. Weedon, Anne Halpin, Andrew R. Wood, Robin N. Beaumont, Seema King, David A. van Heel, Patricia Campbell, William Hagopian, Justine Turner, Richard A. Oram	2020	14
11	Absence of Islet Autoantibodies and Modestly Raised Glucose Values at Diabetes Diagnosis Should Lead to Testing for MODY: Lessons From a 5-Year Pediatric Swedish National Cohort Study Diabetes Care ·Annelie Carlsson, Maggie Shepherd, Sian Ellard, Michael N. Weedon, Åke Lernmark, Gun Forsander, Kevin Colclough, Qefsere Brahimi, Camilla Valtonen‐André, Sten A. Ivarsson, Helena Elding Larsson, Ulf Samuelsson, Eva Örtqvist, Leif Groop, Johnny Ludvigsson, Claude Marcus, Andrew T. Hattersley	2019	73
12	Assessment of MTNR1B Type 2 Diabetes Genetic Risk Modification by Shift Work and Morningness-Eveningness Preference in the UK Biobank Diabetes ·Hassan S. Dashti, Céline Vetter, Jacqueline M. Lane, Matt C. Smith, Andrew R. Wood, Michael N. Weedon, Martin K. Rutter, Marta Garaulet, Frank A. J. L. Scheer, Richa Saxena	2019	11
13	Estimating sleep parameters using an accelerometer without sleep diary Scientific Reports ·Vincent T. van Hees, Sèverine Sabia, Samuel E. Jones, Andrew R. Wood, Kirstie N. Anderson, Mika Kivimäki, Timothy M. Frayling, Allan I Pack, Maja Bućan, Michael I. Trenell, Diego R. Mazzotti, Phil Gehrman, Archana Singh‐Manoux, Michael N. Weedon Hit paper breakdown →	2018	322
14	A Type 1 Diabetes Genetic Risk Score Can Identify Patients With GAD65 Autoantibody–Positive Type 2 Diabetes Who Rapidly Progress to Insulin Therapy Diabetes Care ·Anita L. Grubb, Timothy J. McDonald, Femke Rutters, Louise A. Donnelly, Andrew T. Hattersley, Richard A. Oram, (unknown), Amber A. van der Heijden, Fiona Carr, Petra J. M. Elders, Michael N. Weedon, Roderick C. Slieker, Leen M. ‘t Hart, Ewan R. Pearson, Beverley M. Shields, Angus G. Jones	2018	38
15	Clinical Features and HLA Association of 5-Aminosalicylate (5-ASA)-induced Nephrotoxicity in Inflammatory Bowel Disease Journal of Crohn s and Colitis ·Graham Heap, Kenji So, Michael N. Weedon, Naomi Edney, Claire Bewshea, Abhey Singh, Vito Annese, John Beckly, D. J. Buurman, Rubina Chaudhary, (unknown)	2015	71
16	A partially inactivating mutation in the sodium-dependent lysophosphatidylcholine transporter MFSD2A causes a non-lethal microcephaly syndrome Nature Genetics ·Vafa Alakbarzade, Abdul Hameed, Debra Q Y Quek, Barry A. Chioza, Emma L. Baple, Amaury Cazenave‐Gassiot, Long N. Nguyen, Markus R. Wenk, Arshia Ahmad, Ajith Sreekantan-Nair, Michael N. Weedon, Phil Rich, Michael A. Patton, Thomas T. Warner, David L. Silver, Andrew H. Crosby	2015	117
17	Phosphodiesterase 8B Gene Polymorphism Is Associated with Subclinical Hypothyroidism in Pregnancy The Journal of Clinical Endocrinology & Metabolism ·Beverley M. Shields, Rachel M. Freathy, Bridget Knight, Anita Hill, Michael N. Weedon, Timothy M. Frayling, Andrew T. Hattersley, Bijay Vaidya	2009	23
18	Common variation in the FTO (fused toes) gene is strongly associated with adiposity measures in the northern finnish birth cohort of 1966 Diabetologia ·AJ Bennett, Michael N. Weedon, Eleftheria Zeggini, Rachel M. Freathy, C M Lindgren, Ulla Sovio, Nicholas J. Timpson, A Ruokonen, Hannu Martikainen, Anneli Pouta, A L Hartikainen, Timothy M. Frayling, Andrew T. Hattersley, Marjo‐Riitta Järvelin, M I McCarthy	2007	0
19	Evaluation of Common Variants in the Six Known Maturity-Onset Diabetes of the Young (MODY) Genes for Association With Type 2 Diabetes Diabetes ·Wendy Winckler, Michael N. Weedon, Robert Graham, Steven A. McCarroll, Shaun Purcell, Peter Almgren, (unknown), Daniel Gaudet, Kristina Bengtsson Boström, Mark Walker, G. A. Hitman, Andrew T. Hattersley, Mark I. McCarthy, Kristin Ardlie, Joel N. Hirschhorn, Mark J. Daly, Timothy M. Frayling, Leif Groop, David Altshuler	2007	130
20	Evidence that the LARS2 gene represents a novel type 2 diabetes mellitus gene Diabetologia ·Erwin Reiling, Joost Dekker, Tine Maria Hansen, Michael N. Weedon, Giel Nijpels, G. A. Hitman, Maura E. Walker, M I McCarthy, Oluf Pedersen, Robert J. Heine, J. A. Maassen, Leen M. ‘t Hart	2006	0

About Michael N. Weedon

Michael N. Weedon is a scholar working on Genetics, Endocrinology, Diabetes and Metabolism, Developmental Biology, Surgery and Family Practice, having authored 182 papers that have together received 11.4k indexed citations. Recurring topics across this work include Pancreatic function and diabetes (50 papers), Genetic Associations and Epidemiology (42 papers), Diabetes and associated disorders (36 papers), Diabetes Management and Research (19 papers), Genetics and Neurodevelopmental Disorders (13 papers), Genomics and Rare Diseases (13 papers), Epigenetics and DNA Methylation (12 papers) and RNA modifications and cancer (11 papers). The work is most often cited by research in Genetics (6.1k citations), Endocrinology, Diabetes and Metabolism (2.5k citations), Surgery (2.8k citations), Molecular Biology (3.5k citations) and Physiology (1.2k citations). Michael N. Weedon has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Timothy M. Frayling, Andrew T. Hattersley, Andrew R. Wood, Mark I. McCarthy, Joel N. Hirschhorn, Dennis H. Greer, Beverley M. Shields, Jian Yang, Peter M. Visscher and Richard A. Oram. Their work appears in journals such as Diabetes, Diabetologia, Diabetes Care, The American Journal of Human Genetics and Human Molecular Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact